Probiotic Stability Testing: Why CFU Counts Fall Short of Label Claims Before Expiration

Probiotic supplements are one of the most tested — and most frequently failed — categories in independent supplement quality reviews. Organizations like ConsumerLab.com and NSF International routinely flag probiotic products for CFU count discrepancies, with some analyses finding that more than a third of tested products don’t deliver labeled potency by the time consumers actually open them. The products weren’t necessarily manufactured poorly. In many cases, the formulation and packaging decisions made early in product development simply didn’t account for how vigorously probiotic bacteria resist their own death over 18 to 24 months on a shelf.

US retail sales of probiotic supplements exceeded $7 billion in 2024 according to Nutrition Business Journal, and the category continues to attract new brands — many of whom haven’t grappled seriously with what a rigorous stability program actually requires. That gap between a CFU claim and a CFU reality isn’t just a consumer protection issue. It creates legal exposure, Amazon listing risk, and the kind of quality failure that tends to surface at the worst possible time.

Why Probiotic CFU Counts Drop During Stability Testing

Probiotic bacteria are living organisms, and they respond to their environment — which means every decision you make about formulation, filling, and packaging affects how many viable cells are left when your customer opens the bottle.

Temperature is the dominant stressor. Lactobacillus and Bifidobacterium species — the two most prevalent genera in commercial probiotics — are measurably heat-sensitive. Research has consistently shown storage at 25°C accelerates viability loss compared to refrigerated conditions at 4°C, particularly in powder and encapsulated forms. Accelerated stability testing conducted per ICH Q1A(R2) guidelines — 40°C at 75% relative humidity — regularly reveals CFU loss of 1 to 2 log units within 90 days. For a product labeled at 50 billion CFU, a single log-unit reduction means the consumer may be receiving 5 billion or fewer — just 10% of the claimed dose.

Moisture amplifies that effect. Water activity above 0.3 aw has been shown to accelerate die-off in lyophilized (freeze-dried) probiotic preparations, which constitute the majority of commercially encapsulated formats. Packaging plays an enormous role here. In our own testing work, we consistently see foil-sealed blister packs outperform HDPE bottles with induction seals — sometimes by 0.5 to 1.0 log units at 12 months — particularly in humidity-variable shipping environments and warm storage conditions.

Oxygen exposure during capsule filling and closure degrades oxygen-sensitive strains faster than is generally appreciated. Certain Lactobacillus species and most Bifidobacterium strains are strict or moderate anaerobes. Nitrogen-flushed filling environments and low-permeability capsule materials can meaningfully preserve CFU counts through a 24-month window. But many contract manufacturers don’t offer those conditions as standard, and brands often don’t think to ask.

Formulation interactions are the least understood source of CFU loss. Probiotics blended with botanical extracts, high-dose zinc, certain antioxidants, or acidic vitamin C can face pH stress, oxidative degradation, or direct antimicrobial effects from the co-ingredients. And these effects won’t show up if you’re only testing the probiotic raw material in isolation. The finished formulation — with everything it contains, in the packaging it will be sold in — is the only meaningful unit of analysis.

What “At Manufacture” vs. “At Expiration” Means for Your Label Claim

There are two approaches to CFU labeling in the supplement industry, and the difference between them is more consequential than it appears:

At time of manufacture (AOM): The label reflects the CFU count when the product was filled. It’s the easier claim to substantiate with a single lot release test, but it tells consumers nothing about what they’re actually ingesting. A product labeled “50 billion CFU” at manufacture might deliver 8 billion CFU two years later.

At time of expiration (ATE): The label reflects what the product will contain when it expires. This requires building in an overage at manufacture — producing the product at, say, 80 to 150 billion CFU so the labeled 50 billion remains achievable through expiration. It requires real stability data across multiple time points to substantiate.

The industry is steadily moving toward ATE labeling, and for good reason. The FTC has taken action against supplement companies for unsubstantiated probiotic potency claims, and FDA Warning Letters have cited GMP deficiencies — specifically failures under 21 CFR Part 111 — related to inadequate testing specifications for finished product potency. DSHEA requires that label claims be truthful and not misleading. “50 billion CFU” that degrades to 3 billion by month 12 is difficult to defend as the former.

One detail that frequently catches brands off guard: if your product is labeled for “room temperature” storage, your stability study needs to reflect what room temperature actually means in distribution — warehouses, shipping containers, retail stockrooms. Conditions well above 25°C are common in the summer across much of the US. A stability study run exclusively under ideal laboratory conditions may not represent what your customer receives.

How to Design a Probiotic Stability Study That Actually Holds Up

A defensible probiotic stability program doesn’t require a massive budget. But it does require structure. Here’s the framework we walk brands through:

Step 1: Define your stability-indicating assay. Viable plate count (VPC) per USP <61> is the most widely accepted method for measuring live, cultivable probiotic organisms. For strains that are difficult to culture — some Bifidobacterium species present this challenge — a validated quantitative PCR method targeting species-specific markers may be more appropriate, provided the method distinguishes live from dead cells. Confirm with your testing lab that their method is validated and accredited for your specific strains before you generate a single data point.

Step 2: Select your storage conditions. Real-time stability should be conducted at labeled storage conditions. Accelerated stability at 40°C/75% RH per ICH Q1A(R2) allows you to forecast failure patterns before your real-time data matures. Include at least three production lots — one lot is a snapshot, three lots reveal a trend and satisfy FDA’s GMP expectations for establishing a stability profile.

Step 3: Establish meaningful time points. For a 24-month shelf life, test at 0, 3, 6, 9, 12, 18, and 24 months minimum. Don’t treat early time points as administrative formalities. The 3-month and 6-month results are often where degradation patterns first become predictable — and where you can still adjust packaging, desiccant load, or overage strategy before committing to mass production.

Step 4: Test the finished product in commercial packaging. This is the most commonly skipped step. Brands routinely test probiotic raw materials in bulk rather than the encapsulated, packaged SKU. The capsule shell material, fill blend composition, induction seal integrity, desiccant type and quantity, container headspace, and label-applied moisture barrier all influence real-world stability. If you’re not testing what your consumer will open, your data is answering the wrong question.

Step 5: Set a release specification with appropriate overage. If your ATE label claim is 10 billion CFU, your at-manufacture specification needs to account for expected log-unit loss across your shelf life at your labeled storage condition. A conservative program typically builds in a 0.5 to 1.0 log overage. Confirm with your contract manufacturer what overage they’re already building in — many do this routinely, but documentation and communication aren’t always consistent.

The ISO 17025 Accreditation Factor

Not all stability data carries equal weight with the parties reviewing it. Amazon’s third-party testing requirements, retail buyer audit standards, and FDA GMP expectations all give more credibility to test results generated by ISO 17025 accredited laboratories for the specific methods involved.

ISO 17025 accreditation means the lab has demonstrated — to an independent accreditation body — that its methods produce accurate, reproducible results with defined measurement uncertainty. For probiotic viability testing specifically, where biological variability is inherent, accreditation signals that the lab has done the method validation work to distinguish real signal from noise. A COA from an unaccredited lab, regardless of how the results look, is harder to defend when scrutiny arrives.

At Qalitex, we hold ISO 17025 accreditation for microbiology testing methods applicable to probiotic viability work. When we run stability samples for brands, we flag anomalous early time-point results in real time — not at the 12-month test when options are limited. The value of a testing partnership is in that conversation, not just the data package at the end.

One Test That Changes Everything

Run a real-time stability test on your probiotic’s finished, packaged SKU at the 6-month mark before you finalize a 24-month expiration date. That single data point — 6 months of actual storage at labeled conditions in commercial packaging — will tell you more about your stability trajectory than any accelerated study model alone.

If you’re seeing more than 0.5 log loss at 6 months, you have options: increase overage, switch to a more protective packaging format, add desiccant, or adjust storage conditions before the product reaches mass retail. If you wait until 18 months to discover your CFU counts have collapsed, you’re reacting instead of designing.

Probiotic products that hold their claims through expiration aren’t built on luck or a particularly resilient strain. They’re built on deliberate formulation decisions, packaging that’s been tested rather than assumed, and a stability program designed from the start with the finish line in mind.

---

Written by Nour Abochama, Vice President of Operations, Qalitex Laboratories. Learn more about our team

Talk to our team about your testing needs. Contact us

Related from our network

• FDA GMP Compliance Strategies for Supplement Manufacturers — Aurora TIC covers the regulatory consulting side of 21 CFR Part 111 documentation and audit readiness.
• NHP Testing and Probiotic Compliance in Canada — Androxa supports Health Canada NHP licensing with stability and potency testing for Canadian markets.
• Probiotic Raw Material Supplier Qualification and COA Verification — Ayah Labs specializes in incoming raw material testing and supplier audit support for B2B ingredient buyers.